Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics/pharmacodynamics study of linezolid in severely infected patients
ChiCTR-RNC-10000762Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linezolid in multidrug-resistant Gram-positive bacterial infection (MDRGP) and Infection, sponsored by Chinese PLA General Hospital. Primary endpoints: Plasma concentration and Cumulative fraction of response. Started Jan 2010; status: completed.
02
Drugs
linezolid
03
Conditions
multidrug-resistant Gram-positive bacterial infection (MDRGP)Infection
Beyond the preview
Go deeper on ChiCTR-RNC-10000762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RNC-10000762.